Demographic and baseline characteristics of the study population (n=2843)
| Baseline characteristic | Study population (n=2843) |
| Age—years | 48.7±8.6 (50.7; 43.6–55.6) |
| Male/female—n (%) | 1076 (37.8)/1767 (62.2) |
| Weight—kg | 91.0±14.1 (90.0; 82.0–99.5) |
| Body mass index—kg/m2 | 32.0±4.6 (31.8; 29.2–34.6) |
| Waist circumference—cm | 98.4±12.4 (98.0; 90.0–105.0) |
| Fasting plasma glucose—mmol/L | 5.6±1.4 (5.4; 4.8–6.0) |
| Total cholesterol—mmol/L | 6.3±1.2 (6.2; 5.5–7.1) |
| Serum triglycerides—mmol/L | 2.1±0.9 (1.9; 1.5–2.6) |
| Alanine aminotransferase—U/L | 50.2±33.2 (42.6; 29.0–64.0) |
| Aspartate aminotransferase—U/L | 43.6±25.7 (39.0; 27.0–54.3) |
| Gamma-glutamyl transferase—U/L | 51.7±37.6 (42.0; 30.0–61.0) |
| Ultrasound findings—n (%) | |
| Hepatic steatosis | 2747 (96.6) |
| Hepatomegaly | 1774 (62.4) |
| Increase in portal vein and/or splenic vein diameters | 120 (4.2) |
| Liver fibrosis | 71 (2.5) |
| Liver cirrhosis | 0 (0) |
| Comorbid condition | |
| According to the nature of the disease—n (%)* | |
| Overweight/obesity | 2298 (80.8) |
| Elevated cholesterol | 2122 (74.6) |
| Hypertension | 1642 (57.8) |
| Type 2 diabetes mellitus | 477 (16.8) |
| According to the no of diseases—n (%) | |
| 1 | 580 (20.4) |
| 2 | 1112 (39.1) |
| 3 | 869 (30.6) |
| 4 | 282 (9.9) |
Values are expressed as mean±SD (median; IQR), unless otherwise specified.
Percentages are calculated as n/N.
*Patients may have more than one comorbid condition.